New clinical data surrounding this compound, specifically the 120 milligram formulation referred to as ZPHC, reveal a impressive impact on physique loss and linked health factors. Researchers believe that this combined compound, affecting both GLP-1 and GIP receptors , may offer a noteworthy breakthrough in the management of excess weight and asso